Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

MAY 5, 2023

Around the world, investors are favoring companies that have proven their profitability and that can demonstrate how they have successfully utilized their capital. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

Owler

MAY 17, 2023

. + Series A Funding Round Results in $59M for Taichu Biotech A China-based provider of drug development and evaluation services for the biopharmaceutical industry, Taichu Biotech raised $59M in funds. Everseen Raises $71.3M in Series A funding.

Biotech 52

Biotech Travel Capital Entertainment 52

Owler

JUNE 14, 2023

The funding round was led by venture capital firm Andreessen Horowitz. in Funding Founded in 2014, venture capital firm Swanlaab Venture Factory says it, “aims to invest in early-stage Spanish startups with B2B business models and clear technological differentiation.” Swanlaab Venture Factory Receives $48.1M

Biotech 52

Biotech Startups Capital Research 52

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59

Biotech Research Loss Algorithm 59

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. Safaii Board Member Matthew is the founder of Arrowroot Capital. He holds B.A. He is also an entrepreneur.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

APRIL 19, 2024

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. Over the past few years, the technology industry has experienced dramatic highs and lows. 2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion.

Technology 69

Technology Technology Retail Biotech 69

Wink Intel

FEBRUARY 23, 2021

tech and biotech ETFs and two fixed income components. “By balancing risk and then seeking returns, this index aims to provide stable returns in many market environments.”. Credit Suisse Tech Edge Index (Ticker: CSEATEDG): The excess return index combines four U.S

Intellectual Property 40

Intellectual Property Banking Biotech Retail 40

Alpha Sense BI

NOVEMBER 9, 2022

A lot of the improvements that I talked about on a macro level, capital efficiency, operations improvements are as important internationally as they are in North America.” – Brian T. M&A IPOs to watch in Pharma and Biotech. Capital deployment and business development were a big focus during the call. JOYY Inc. [YY].

Sales 52

Sales Loss Capital Biotech 52

CIO

MARCH 4, 2025

Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products. Many Fortune 500 companies now invest in AI, robotics and biotech startups through corporate venture arms, gaining insights and strategic advantage.

Technology 442

Technology Technology Biotech Business 442

Alpha Sense BI

MARCH 4, 2024

.” – Associate Director, Pharmaceutical Company | Expert Transcript Identifying Drug Targets and Candidates Traditional methods are mostly based on singular hypothesis-driven approaches and are limited by human capacity to analyze multi-dimensional data, which means they are prone to human error and bias.

Biotech 52

Biotech Pharmaceutical Intelligence Intelligence 52

Alpha Sense BI

MARCH 13, 2024

According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs. In January, Roche completed the $2.7

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

The industries using expert networks the most are: information technology, industrials, media, healthcare , pharmaceutical, biotech, energy, consulting, asset management, hedge funds , private equity, venture capital, investment banking, and sell-side equity research. How do various industries benefit from expert networks?

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52

Alpha Sense BI

MARCH 14, 2025

The venture capital sector is poised for a long-awaited return to dealmaking, fund deployment, and exit opportunities in 2025. Data from the National Venture Capital Association (NVCA) illustrates a massive backlog in VC exits. To train these models requires so much capital that only hyperscalers are going to be able to compete today.

Capital 59

Capital Biotech Startups Finance 59

Alpha Sense BI

FEBRUARY 6, 2025

Capital Ones Acquisition of Discover Financial: $35.3 The FTC has not yet stated whether it intends to block the deal, but some Capital One customers have brought a class-action lawsuit in an attempt to block the merger. The deal would potentially reshape the U.S. Verizons Acquisition of Frontier Communications: $19.6

Biotech 59

Biotech Capital Pharmaceutical Finance 59

Happy Market

MAY 9, 2022

We started this company in – I sort of kind of started it I guess in 2007, but we were really starting to raise capital and get the business off the ground in 2008, which was a horrific economic climate.

Management 52

Management Entertainment Market Research Marketing Research 52

Alpha Sense BI

JANUARY 8, 2025

RFK), have clouded 2025 visibility for the healthcare sector and generated a mix of expectations for healthcare systems and providers, health insurers, and biotech/pharma companies. Director with a large managed care organization Biotech and Pharma The Trump administration is expected to bring a relaxation of antitrust enforcement.

Innovation 69

Innovation Biotech Pharmaceutical Benchmarking 69